Sangamo Therapeutics

SGMO

NASDAQHealth Care

Income Statement

Total Revenue$57.8M

Gross Profit$57.8M

Operating Income$-103.97M

EBITDA$-88.75M

EBIT$-98.11M

Pre-tax Income$-124.02M

Net Income$-97.94M

Cash Equivalent$41.81M

Total Debt$28.47M

Book Value$35.57M

Book Value Per Share0.18

Return on Equity (ROE)-430.13%

Return on Assets (ROA)-96.37%

Return on Invested Capital (ROI)-430.13%

Net Profit Margin-169.45%

Current Ratio1.13

Quick Ratio1.02

Long-Term Debt / Equity0.00